Summary
This prediction ended on 14.12.24 with a price of €570.00. With a performance of 51.60% the BUY prediction by BiotechBee was a big success. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Argenx SE | - | - | - |
| iShares Core DAX® | 3.002% | 3.742% | 24.169% |
| iShares Nasdaq 100 | 2.966% | 1.308% | 9.141% |
| iShares Nikkei 225® | 5.606% | 4.472% | 21.237% |
| iShares S&P 500 | 2.312% | 1.880% | 6.333% |
According to BiotechBee what are the pros and cons of Argenx SE for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Argenx SE diskutieren
Buy mit Kursziel 450,0